[Prevalence of non-vaccinable high risk genotypes of human papillomavirus in the Early Detection of Cervical Cancer Program in Cantabria].

Autor:	Paz-Zulueta M; Departamento de Enfermería, Universidad de Cantabria, Cantabria, España. Electronic address: maria.paz@unican.es., Fernández-Feito A; Área de Enfermería, Facultad de Medicina y Ciencias de la Salud, Universidad de Oviedo, Asturias, España., Amparán Ruiz M; Gerencia de Atención Primaria, Servicio Cántabro de Salud, Cantabria, España., Azofra Olave A; Gerencia de Atención Primaria, Servicio Cántabro de Salud, Cantabria, España., Martín Seco Y; Gerencia de Atención Primaria, Servicio Cántabro de Salud, Cantabria, España., Ojugas Zabala S; Gerencia de Atención Primaria, Servicio Cántabro de Salud, Cantabria, España., Otero García A; Gerencia de Atención Primaria, Servicio Cántabro de Salud, Cantabria, España., Royano Rasines C; Gerencia de Atención Primaria, Servicio Cántabro de Salud, Cantabria, España., Sarabia-Lavín R; Departamento de Enfermería, Universidad de Cantabria, Cantabria, España., Torres Manrique B; Departamento de Enfermería, Universidad de Cantabria, Cantabria, España., Santibáñez Margüello M; Departamento de Ciencias Médicas y Quirúrgicas, Universidad de Cantabria-IDIVAL, Cantabria, España.
Jazyk:	Spanish; Castilian
Zdroj:	Atencion primaria [Aten Primaria] 2016 Jun-Jul; Vol. 48 (6), pp. 347-55. Date of Electronic Publication: 2015 Oct 29.
DOI:	10.1016/j.aprim.2015.07.006
Abstrakt:	Objective: To estimate the prevalence of infection with non-vaccinable high risk genotypes of human papillomavirus (HPV). Design: Cross-sectional study. Location: Seven randomly selected health centres in Cantabria (Northern Spain). Participants: All women with an evaluable vaginal smear (n=3,359) between 2010 and 2011. Main Measures: The variables collected were cytological diagnosis, PCR results, and family planning method. The vaginal smear results were classified with the Bethesda system. The classification by Muñoz et al. was used for typing as oncogenic risk HPV. Proportions and odds ratio (OR) were estimated with corresponding confidence intervals at 95% (95% CI). Results: The prevalence of HPV infection was 2.71% (95% CI: 2.15 to 3.27). The prevalence of high oncogenic risk HPV genotypes was 2.26%; (95% CI: 1.75 to 2.78). The most frequent genotype was 16 (28.89%). More than half of the women were positive for one of the non-vaccinable high risk genotypes: 51 (18.89%) and 58 (13.33%) and 68 (12.22%) or 31 (11.11%). At least two non-vaccinable high-risk genotypes co-existed in 23.33% of women. Younger women (≤30 years) had twice the risk of any HPV infection: OR 2.01 (95% CI: 1.02 to 3.96); and were twice as likely to use condoms compared to hormonal contraceptives, OR 2.09 (95% CI: 1.64 to 2.67). Conclusions: According to the high percentage of non-vaccinable high oncogenic risk HPV types, there should be a re-think of the prevention strategy in the population, who may have a false sense of protection. (Copyright © 2015 Elsevier España, S.L.U. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu